SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 268.23 |
| Enterprise Value ($M) | 140.13 |
| Book Value ($M) | 179.25 |
| Book Value / Share | 3.56 |
| Price / Book | 1.50 |
| NCAV ($M) | 111.71 |
| NCAV / Share | 2.22 |
| Price / NCAV | 2.40 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.60 |
| Return on Assets (ROA) | -0.44 |
| Return on Equity (ROE) | -0.56 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.07 |
| Current Ratio | 5.07 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 236.21 |
| Assets | 303.75 |
| Liabilities | 124.50 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -143.31 |
| Net Income | -135.35 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -43.80 |
| Cash from Investing | 88.80 |
| Cash from Financing | 27.49 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Price T Rowe Associates Inc /md/ | 10.20 | 3.14 | |
| 13G/A | Avoro Capital Advisors LLC | 9.10 | 4.86 | |
| 13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 | |
| 13G | Baker Bros. Advisors Lp | 9.80 | ||
| 13G/A | BlackRock Inc. | 4.70 | -34.08 | |
| 13G/A | Fmr Llc | 11.06 | -10.94 | |
| 13D/A | Versant Venture Capital VI, L.P. | 13.70 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 9,618 | 80,350 | 11.97 | |
| 11,101 | 41,457 | 26.78 | |
| 31,973 | 44,121 | 72.47 | |
| 7,670 | 35,951 | 21.33 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GBIO – Generation Bio Co. | GERN – Geron Corporation |
| GILD – Gilead Sciences, Inc. | GOSS – Gossamer Bio, Inc. |
| GRTS – Gritstone bio, Inc. |
Financial data and stock pages provided by
Fintel.io